Shangai, China

Xiaoyan Li

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):

Title: Inventor Xiaoyan Li: Pioneering Advances in Nucleic Acid Detection

Introduction: Xiaoyan Li is a prominent inventor based in Shanghai, China, known for her innovative contributions to biotechnology. With two patents to her name, she has made significant advancements in methods for detecting target nucleic acid molecules, which are crucial for various applications in medical diagnostics and research.

Latest Patents: Xiaoyan Li's latest patents focus on the application of Cas proteins and methods for detecting target nucleic acid molecules. The patent outlines a procedure that involves adding a guide RNA, a Cas12a protein, and a nucleic acid probe into a reaction system containing the target nucleic acid to be detected. This method facilitates the identification of specific nucleic acid sequences, showcasing her dedication to enhancing detection technologies.

Career Highlights: Currently employed by Shanghai Tolo Biotechnology Company Limited, Xiaoyan Li continues to lead cutting-edge research in her field. Her expertise has been instrumental in her company's mission to develop innovative biotechnological solutions that address critical health challenges.

Collaborations: Xiaoyan has worked alongside talented colleagues, including Jin Wang and Qiuxiang Cheng, fostering a collaborative environment that encourages creativity and the sharing of ideas. Together, they push the boundaries of biotechnology, resulting in advancements that could revolutionize diagnostics.

Conclusion: Xiaoyan Li's work as an inventor reflects her commitment to advancing scientific knowledge and improving healthcare solutions. Her patents in nucleic acid detection underscore her role as a significant contributor to the field of biotechnology, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…